LONDON, June 18, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Synthetic Biology in US$ Thousands by the following Product Segments: Enabled Products, and Others. The report also analyzes the market by the following Application Areas: Energy and Chemicals, Biotechnology and Pharmaceuticals, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 51 companies including many key and niche players such as -
Amyris, Inc.
BP PLC
Chromatin Inc.
Evolva SA
Gevo, Inc.
Download the full report: https://www.reportbuyer.com/product/1375238/
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
II. EXECUTIVE SUMMARY
1. OUTLOOK II-1
A Quick Primer II-1
Synthetic Biology: Prediction Becoming Reality II-1
Current and Future Analysis II-3
Analysis by Region II-3
Analysis by Product Segment II-4
Analysis by End-Use Market II-4
Key Growth Drivers and Major Concerns II-5
Growth Drivers II-5
Major Concerns II-5
Future Outlook II-6
2. INDUSTRY OVERVIEW II-7
Synthetic Biology - An Emerging Discipline in Need of Promotion II-7
Contribution of Synthetic Biology to Biotech II-7
Craig Venter's Synthetic Life: Momentous Achievement in
Synthetic Biology Field II-7
Gibson Assembly®: Building Toolset for Synthetic Biology II-8
Gen9's BioFab: Major Breakthrough in Synthetic Biology II-8
Key Developments in the Synthetic Biology Field: A Synopsis II-9
Synthetic Biology Products with Commercial Potential in the
Future by End Market II-11
Competitive Landscape II-12
Competition in Synthetic Biology Market II-12
Intrexon: Leader in Synthetic Biology Field II-13
Key Factors Contributing to Intrexon's Success in Synthetic
Biology Field II-13
Proprietary Suite of Innovative Technologies II-13
Unique ECC-based Business Model II-14
A Synopsis of Intrexon's ECC Agreements: 2011-2013 II-15
3. MARKET TRENDS, DRIVERS, AND ISSUES II-16
Is Synthetic Biology a Bane or Boon? II-16
Synthetic Biology Exhibits Plateau in Awareness II-16
Synthetic Biology Research Gathers Momentum II-16
US and Europe - Propelling Research in the Field of Synthetic
Biology II-17
Table 1: Number of Entities Focused on Synthetic Biology
Research Globally: 2009 & 2013 (includes corresponding
Graph/Chart) II-17
Table 2: Synthetic Biology and their Potential Areas of
Applications Being Researched by Biological Systems
Manufacturers/Designers (includes corresponding Graph/Chart) II-18
Table 3: Number of Biological Systems
Manufacturers/Designers Focused on Specialty/Fine Chemical
Applications (includes corresponding Graph/Chart) II-19
Table 4: Number of Patent Filings Related to Synthetic
Biology: 2003-2013 (includes corresponding Graph/Chart) II-20
Table 5: Leading Filers of Patent Applications Related to
Synthetic Biology: 2003-2013 (includes corresponding
Graph/Chart) II-21
Synthetic Biology Mired by Challenges in Developing Countries II-22
Synthetic Biology Bringing a Paradigm Shift in the Field of
Biological Research II-22
DNA Sequencing Technique Propelling Growth for Synthetic Biology II-23
Plummeting Cost of DNA Sequencing Bolsters Market Growth II-23
Table 6: Cost per Genome Sequencing: 2001-2014 II-24
Systems Biology Leading to Advancements in Synthetic Biology II-24
Synthetic Biology based Microbial Factories for Production of
Poppies II-24
Food and Other Basic Needs' Scarcity to Fuel Synthetic Biology
Market II-25
Food, Water, and Energy Statistics II-25
Table 7: Top 20 Countries Worldwide in Terms of Population
in Million (2014) (includes corresponding Graph/Chart) II-26
Will Synthetic Biology Mitigate Food Security Concerns? II-26
Growing Demand for GM Crops Opens Up Growth Avenues II-27
Synthetic Biology-based Ingredients Gain Traction II-28
Role of Synthetic Biology in Producing Plants with Desirable
Characteristics II-28
Do-It-Yourself Biology (DIYBio): A Growing Phenomenon II-29
Synthetic Biology Ingredients in Consumer Products - Laden
with Concerns II-30
Synthetic Biology Gaining Prominence in Biomedical Applications II-30
Research Efforts in Full Swing to Treat Life-Threatening
Diseases using Synthetic Biology II-31
Synthetic Biology Therapeutics to Address Antibiotic-
Resistance Crisis II-32
Pipeline Perspective of Synthetic Biology Therapeutics (
Synthetic Biologics and Intrexon Collaboration) II-33
Synthetic Biology for Wildlife Conservation Laden with Risks II-33
Synthetic Biology Enabling Creation of Advanced Biosensing
Systems II-33
Synthetic Biology Gains Significance in Production of Bio-
Based Chemicals and Biofuels II-34
Contribution of Synthetic Biology to Renewable Chemicals II-35
Synthetic Biology for Energy Supply: Potential Threat to
Biodiversity II-37
SynBio Products and Ingredients Face Opposition from Several
Organizations II-37
Lack of Regulatory Framework - A Major Concern II-38
4. KEY RESEARCH FINDINGS ON SYNTHETIC BIOLOGY II-39
Biologists Implants Artificial Chromosome in Yeast to Create
Artificial Life II-39
Synthetic Genes to Open New World of Drug Development II-39
Researchers Announce Production of Peptoid Nanosheets II-40
Synthetic Biology in Repelling Viruses II-40
Synthetic Biology in Engineered Food II-40
Synthetic Biology to Address Issues Related to Algal Blooms II-41
Synthetic Biology Holds Potential for Testing Water Purity II-41
Mars - A Home Away from Home Courtesy Synthetic Biology II-41
Predictable Biological Systems - No More a Myth II-41
Researchers at JCVI Make Novel Advances in Synthetic Genomics II-41
Synthetic Biology Tools Can Detect Listeria Contamination in
Food Products II-42
Synthetic Biology Accelerates Flu Vaccine Production II-42
Bioengineers at Duke University Develops Novel System for
Reproducing Natural Complex Gene Regulation II-43
TALE: A Viable Technology for Synthetic Protein Development II-43
Can Synthetic Biology Fuel Cars or Household Power Supplies
Using Naturally-Existing Fatty Acids? II-43
Researchers Engineered Synthetic Compound to Defend Iron
Deficiency II-44
Cellular Circuit Designing Made Possible through Biological Genes II-44
Meshing Inputs/Outputs Offer Layered Circuits II-45
Cambrian Genomics Pioneers DNA Laser Printer II-45
Researchers Develop Novel Technique that Speeds the Process
for Developing New Biological Parts II-45
Researchers Develop Novel Biological Device that Mimics
Transistor-Like Properties II-46
5. SYNTHETIC BIOLOGY - AN OVERVIEW II-47
Introduction II-47
Historical Background II-47
Synthetic Biology Vis-à-vis Genetic Engineering - A Comparison II-47
Scope of Synthetic Biology in Various Fields II-48
Engineering II-48
Chemistry II-48
Major Enabling Technologies II-48
Sequencing II-48
Fabrication II-49
Modeling II-49
Measurement II-49
Synthetic Biology Market - By Product II-49
Core Products/Biologic Components II-49
Synthetic Genes II-49
Synthetic Cells II-50
Chassis Organisms II-50
Escherichia coli II-51
Bacillus subtilis II-51
Yeast II-51
Mycoplasma II-51
Acinetobacter II-51
Mycoplasma genitalium II-51
XNA (Xeno Nucleic Acid) II-51
Enabling Products II-52
DNA Synthesis II-52
Oligonucleotide Synthesis II-52
Market Potential II-53
Pharmaceutical II-53
Industrial II-53
Agriculture II-53
Life Sciences Research II-53
Renewable Energy II-53
Synthetic Biology Applications/Products with Highest
Potential for Commercialization by 2030 II-54
Potential Uses II-54
Biomedicine II-55
Intricate Molecular Devices Utilized for Tissue
Regeneration/Repair II-55
Smart Drugs II-55
Biological Delivery Systems II-55
Vectors for Therapy II-55
Personalized Medicine II-55
Cells with Novel Properties for Betterment of Human Health II-55
In Vivo Synthesis of Small-Molecule Pharmaceuticals II-56
Intricate Natural Products II-56
Expansion of Chemistry of Life II-56
Expanding Genetic Alphabet II-56
Nucleic Acids II-56
Proteins II-57
New Imaging and Targeting Methods II-57
Chemical Industry Sustainability II-57
Eco-friendly Production of Chemicals II-57
Energy and Environment II-57
Bioremediation II-57
Energy Production II-57
Biomaterials and Smart Materials Production II-57
Synthesis II-58
Organization II-58
Socio-Economic Concerns and Risks of Synthetic Biology II-58
Production of Bio-Weapons II-58
Accidental Release II-58
Return on Investment II-58
Dissonance with Other Disciplines II-58
Continuous Evolution II-59
Curtailed Understanding II-59
Unpredictable Ecosystem Effects II-59
Unexpected Transfer of Genes II-59
Aggravating Problems II-59
Industry Associations II-59
Synthetic Biology Industry Association (SynBIA) II-59
Industry Association of Synthetic Biology (IASB) II-60
6. PRODUCT INNOVATIONS/INTRODUCTIONS II-61
Synthetic Biologics Obtains Orphan Drug Designation for SYN-
005 mAb II-61
Agilent Technologies Introduces SureGuide Kits II-61
Agilent Technologies Rolls Out ClearSeq AML Next-Generation
Sequencing Cancer Research Panels II-61
Gen9 Rolls Out Variant Libraries II-61
Gen9 Introduces GeneByte Plus™ DNA Constructs II-61
Agilent Technologies Introduces SureSelect Clinical Research
Exome II-61
Agilent Technologies Launches QuikChange HT Protein
Engineering Synthetic Biology System II-62
GenScript Introduces GenEZ™ Next-Generation Molecular Cloning
Service II-62
DNA2.0 Releases CRISPR/Cas9 Tools for Genome Editing and
Engineering II-62
GenScript Unveils GenPlus™ Next-Generation Gene Synthesis
Technology II-62
Life Technologies Introduces new GeneArt® Algae Protein
Expression Kits II-62
Life Technologies Unveils Vector NTI® Express Designer
Bioinformatics Software Platform II-62
Gen9 Introduces GeneBytes™ DNA Constructs II-62
New England Biolabs and Synthetic Genomics Launches Gibson
Assembly Cloning Kit and NEBuilder™ Primer Design Tool II-63
GenScript Introduces Gene-Brick™ Gene Synthesis Service II-63
7. RECENT INDUSTRY ACTIVITY II-64
Genome Compiler Enters into Collaborative Agreement with DNA2.0 II-64
Eurofins Genomics Enters into Co-operation Agreement with Igenbio II-64
Bacterial Robotics Signs Strategic Agreement with Bacmine II-64
Intrexon and Histogenics Enter into Exclusive Channel
Collaboration for Cartilage Repair Therapies II-64
Intrexon and Amneal Pharmaceuticals Announce Second Exclusive
Channel Collaboration for a Target API II-64
Synthetic Biologics and FUJIFILM Diosynth Biotechnologies
Announces Positive Phase I Outcomes of API Manufacturing of
SYN-004 II-64
Evolva Holding Acquires Prosarix II-65
Igenbio Collaborates with Genome Compiler II-65
Pareto Biotechnologies Enters into Technology Partnership with
DNA2.0 II-65
Roche Enters into Research Agreement with Stratos Genomics II-65
Cellectis Enters into Agreement with Thermo Fisher Scientific II-65
Roche Acquires Genia Technologies II-65
Synthorx, a New Synthetic Biotechnology Company Launches II-65
Synthetic Genomics Enters into Long-Term R&D Agreement with
Lung Biotechnology II-65
OriGene Introduces Genome-wide Gene-knockout Kits II-66
Intrexon Concludes Acquisition of Medistem II-66
Amyris Enters into Collaborative R&D Agreement with BASF II-66
MIT SBC Collaborates with Pfizer II-66
Tauriga Sciences Acquires Pilus Energy LLC II-66
OvaScience and Intrexon Enter into Agreement II-66
Sanofi Commences Large-Scale Production of Semi-Synthetic
Artemisinin II-66
EVOLVA and IFF Enter into Pre-Manufacturing Phase for Natural
Vanillin II-67
Synthetic Genomics Enters into Research Agreement with ExxonMobil II-67
Amyris Signs Long Term Agreement with International Flavors &
Fragrances II-67
SGI-DNA and IDT Announce Expanded Collaboration II-67
College of Engineering Establishes BU Center of Synthetic Biology II-67
Gen9 Enters into Partnership with Agilent Technologies II-67
AquaBounty Technologies Enters into Exclusive Channel
Collaboration with Intrexon II-67
Synthetic Biologics Collaborates with Intrexon for Infectious
Disease Therapies II-67
DuPont Collaborates with OligoCo II-68
DNA2.0 Collaborates with Newcastle University II-68
Amyris Secures Contract from the US DARPA II-68
Pfenex Collaborates with DNA2.0 II-68
Synthetic Genomics Inks Agreement with New England Biolabs II-68
Amyris Commences Production of Biofene in Brazil II-68
8. FOCUS ON SELECT PLAYERS II-69
Players Focused on Synthetic Biology Applications II-69
Amyris, Inc. (US) II-69
BP PLC. (UK) II-70
Chromatin Inc. (US) II-70
Evolva SA (Switzerland) II-71
Gevo, Inc. (US) II-71
Joule Unlimited, Inc. (US) II-72
Metabolix (US) II-72
MorphoSys AG (Germany) II-72
Sapphire Energy, Inc. (US) II-73
Solazyme, Inc. (US) II-73
Synthetic Biologics, Inc. (US) II-73
Synthetic Genomics, Inc. (US) II-74
Players Focused on Gene Synthesis and Tools II-74
454 Life Sciences (US) II-74
Agilent Technologies Inc. (US) II-75
ATG Biosynthetics GmbH (Germany) II-75
DNA2.0 (US) II-76
Epoch Life Science, Inc. (US) II-76
Gen9, Inc. (US) II-77
GenScript USA, Inc. (US) II-77
Gingko Bioworks, Inc. (US) II-78
Intrexon Corporation (US) II-78
LC Sciences LLC (US) II-79
Life Technologies Corp. (US) II-79
OPXBIO, Inc. (US) II-80
OriGene Technologies, Inc. (US) II-80
Sangamo BioSciences, Inc. (US) II-81
Verdezyne, Inc. (US) II-81
9. GLOBAL MARKET PERSPECTIVE II-82
Table 8: World Recent Past, Current & Future Analysis for
Synthetic Biology by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2014 through 2020 (includes corresponding Graph/Chart) II-82
Table 9: World Historic Review for Synthetic Biology by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2007 through 2013
(includes corresponding Graph/Chart) II-83
Table 10: World 14-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific and Rest of World
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) II-84
Table 11: World Recent Past, Current & Future Analysis for
Synthetic Biology by Product Segment - Enabled Products and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2014 through 2020 (includes
corresponding Graph/Chart) II-85
Table 12: World Historic Review for Synthetic Biology by
Product Segment - Enabled Products and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2007 through 2013 (includes corresponding
Graph/Chart) II-86
Table 13: World 14-Year Perspective for Synthetic Biology by
Product Segment - Percentage Breakdown of Dollar Sales for
Enabled Products and Others Markets for Years 2007, 2015 &
2020 (includes corresponding Graph/Chart) II-87
Table 14: World Recent Past, Current & Future Analysis for
Synthetic Biology by End-Use Sector - Energy & Chemicals,
Biotechnology & Pharmaceuticals, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2014 through 2020 (includes corresponding
Graph/Chart) II-88
Table 15: World Historic Review for Synthetic Biology by
End-Use Sector - Energy & Chemicals, Biotechnology &
Pharmaceuticals, and Others Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2007
through 2013 (includes corresponding Graph/Chart) II-89
Table 16: World 14-Year Perspective for Synthetic Biology by
End-Use Sector - Percentage Breakdown of Dollar Sales for
Energy & Chemicals, Biotechnology & Pharmaceuticals, and
Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) II-90
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Current & Future Analysis III-1
Research in the US III-1
Table 17: Number of Entities Focused on Synthetic Biology
Research in the US (2009 & 2013) (includes corresponding
Graph/Chart) III-1
International Genetically Engineered Machine (IGEM) - A
Platform for Innovations III-2
Product Launches III-2
Strategic Corporate Developments III-4
Key Players III-9
B.Market Analytics III-19
Table 18: US Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2014 through 2020
(includes corresponding Graph/Chart) III-19
Table 19: US Historic Review for Synthetic Biology Market -
Analyzed with Annual Sales Figures in US$ Thousand for Years
2007 through 2013 (includes corresponding Graph/Chart) III-20
2. CANADA III-21
Market Analysis III-21
Table 20: Canadian Recent Past, Current & Future Analysis
for Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2014 through 2020
(includes corresponding Graph/Chart) III-21
Table 21: Canadian Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-22
3. JAPAN III-23
Market Analysis III-23
Table 22: Japanese Recent Past, Current & Future Analysis
for Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2014 through 2020
(includes corresponding Graph/Chart) III-23
Table 23: Japanese Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-24
4. EUROPE III-25
A.Market Analysis III-25
Current & Future Analysis III-25
Research in Europe III-25
Table 24: Number of Entities Focused on Synthetic Biology
Research in Europe (2009 & 2013) (includes corresponding
Graph/Chart) III-26
Table 25: Number of Entities Focused on Synthetic Biology
Research by Area of Interest: 2013 (includes corresponding
Graph/Chart) III-27
B.Market Analytics III-28
Table 26: European Recent Past, Current & Future Analysis
for Synthetic Biology by Geographic Region - France,
Germany, Italy, UK, Spain and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-28
Table 27: European Historic Review for Synthetic Biology by
Geographic Region - France, Germany, Italy, UK, Spain and
Rest of Europe Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2007 through 2013
(includes corresponding Graph/Chart) III-29
Table 28: European 14-Year Perspective for Synthetic Biology
by Geographic Region - Percentage Breakdown of Value Sales
for France, Germany, Italy, UK, Spain and Rest of Europe
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-30
4a. FRANCE III-31
A.Market Analysis III-31
Current & Future Analysis III-31
Strategic Corporate Development III-31
B.Market Analytics III-32
Table 29: French Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2014 through 2020
(includes corresponding Graph/Chart) III-32
Table 30: French Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-33
4b. GERMANY III-34
A.Market Analysis III-34
Current & Future Analysis III-34
Key Players III-34
B.Market Analytics III-35
Table 31: German Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2014 through 2020
(includes corresponding Graph/Chart) III-35
Table 32: German Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-36
4c. ITALY III-37
Market Analysis III-37
Table 33: Italian Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-37
Table 34: Italian Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-38
4d. THE UNITED KINGDOM III-39
A.Market Analysis III-39
Current & Future Analysis III-39
Market Overview III-39
UK Government Awards Over £6 Million Grant for Synthetic
Biology III-39
UK Government Funding for Synthetic Biology: 2013 III-40
Synbicite Centre to Spearhead UK Research In Synthetic Biology III-40
UK Sets Up New Synthetic Biology Research Centers III-40
Synthetic Biology Research Centre Nottingham (Sbrc Nottingham) III-40
Bristol Centre for Synthetic Biology (Brissynbio) III-41
Openplant Synthetic Biology Research Centre III-41
University of Edinburgh inks Agreement with Bgi to Develop
Artificial Yeast Genome III-41
Strategic Corporate Development III-41
BP Plc. - A Key Player III-42
B.Market Analytics III-43
Table 35: UK Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2014 through 2020
(includes corresponding Graph/Chart) III-43
Table 36: UK Historic Review for Synthetic Biology Market -
Analyzed with Annual Sales Figures in US$ Thousand for Years
2007 through 2013 (includes corresponding Graph/Chart) III-44
4e. SPAIN III-45
A.Market Analysis III-45
Current & Future Analysis III-45
Strategic Corporate Development III-45
B.Market Analytics III-46
Table 37: Spanish Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-46
Table 38: Spanish Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-47
4f. REST OF EUROPE III-48
A.Market Analysis III-48
Current & Future Analysis III-48
Evolva SA (Switzerland) - A Major Player III-48
B.Market Analytics III-49
Table 39: Rest of Europe Recent Past, Current & Future
Analysis for Synthetic Biology Market - Analyzed with Annual
Sales Figures in US$ Thousand for Years 2014 through 2020
(includes corresponding Graph/Chart) III-49
Table 40: Rest of Europe Historic Review for Synthetic
Biology Market - Analyzed with Annual Sales Figures in US$
Thousand for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-50
5. ASIA-PACIFIC III-51
A.Market Analysis III-51
Current & Future Analysis III-51
Table 41: Number of Entities Focused on Synthetic Biology
Research in Asia and Oceania in 2013 (includes
corresponding Graph/Chart) III-51
B.Market Analytics III-52
Table 42: Asia-Pacific Recent Past, Current & Future
Analysis for Synthetic Biology Market - Analyzed with Annual
Sales Figures in US$ Thousand for Years 2014 through 2020
(includes corresponding Graph/Chart) III-52
Table 43: Asia-Pacific Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-53
6. REST OF WORLD III-54
A.Market Analysis III-54
Current & Future Analysis III-54
Strategic Corporate Development III-54
B.Market Analytics III-55
Table 44: Rest of World Recent Past, Current & Future
Analysis for Synthetic Biology Market - Analyzed with Annual
Sales Figures in US$ Thousand for Years 2014 through 2020
(includes corresponding Graph/Chart) III-55
Table 45: Rest of World Historic Review for Synthetic
Biology Market - Analyzed with Annual Sales Figures in US$
Thousand for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-56
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 51 (including Divisions/Subsidiaries - 52)
The United States (41)
Canada (1)
Europe (8)
- France (1)
- Germany (3)
- The United Kingdom (1)
- Spain (1)
- Rest of Europe (2)
Asia-Pacific (Excluding Japan) (2)
Download the full report: https://www.reportbuyer.com/product/1375238/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article